$0.00
(+0.00%
) Quote detailsUSD
( +0.00%
At Close (As of Jan 1, 1970)
$50.65B
Market Cap
41.33
P/E Ratio
19.65
EPS
$855.46
52 Week High
$510.06
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
argenx NV, headquartered in Breda, the Netherlands, is a pioneering clinical-stage biotechnology firm dedicated to developing innovative antibody-based therapies for severe autoimmune diseases, hematological disorders, and cancer. The company utilizes its proprietary technology platform to advance promising candidates through various clinical trial phases, aiming to deliver transformative treatments that address significant unmet medical needs. With a robust pipeline and a strategic focus on leveraging scientific breakthroughs, argenx offers an attractive investment opportunity for institutional investors looking to capitalize on the growth potential of the biopharmaceutical industry.
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD